Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-17

Clinical Trial Update: Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia [Phase 1]

View source ↗

Summary

This completed Phase 1 study evaluated infrared coagulation as a preventive approach for anal cancer in HIV-positive individuals with anal neoplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Anal Cancer, Precancerous Condition | Phase 1 | Status: COMPLETED